BGI
ORKA

B Group Inc’s Oruka Therapeutics ORKA Stock Holding History

B Group Inc’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.14M Hold
75,000
– – 3.35% 11
2026
Q1 		$3.68M Hold
75,000
– – 2.73% 14
2025
Q4 		$2.27M Hold
75,000
– – 1.68% 14
2025
Q3 		$1.44M Hold
75,000
– – 1.06% 16
2025
Q2 		$841K Buy
75,000
+16,785
+29% +$175K 0.65% 17
2025
Q1 		$597K Buy
58,215
+38,215
+191% +$477K 0.51% 18
2024
Q4 		$388K Buy
+20,000
New +$488K 0.24% 17

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

B Group Inc's ORKA Position: Q2 2026 in Review

B Group Inc held its Oruka Therapeutics (ORKA) position steady in Q2 2026 at 75,000 shares worth $7.14M. The position accounts for 3.35% of the portfolio, ranked #11.

B Group Inc first reported a position in ORKA in Q4 2024 and has held it in 7 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • B Group Inc held 75,000 shares of Oruka Therapeutics worth $7.14M as of Q2 2026.
  • B Group Inc left its Oruka Therapeutics share count unchanged in Q2 2026.
  • Oruka Therapeutics made up 3.35% of B Group Inc's portfolio in Q2 2026, its #11 holding.
  • B Group Inc first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on B Group Inc's 13F filing for Q2 2026, filed 14 Aug 2026.